Immunocore Holdings PLC
NASDAQ:IMCR

Watchlist Manager
Immunocore Holdings PLC Logo
Immunocore Holdings PLC
NASDAQ:IMCR
Watchlist
Price: 35.98 USD -0.08%
Market Cap: 1.8B USD

Wall Street
Price Targets

IMCR Price Targets Summary
Immunocore Holdings PLC

Wall Street analysts forecast IMCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMCR is 69.77 USD with a low forecast of 36.36 USD and a high forecast of 105 USD.

Lowest
Price Target
36.36 USD
1% Upside
Average
Price Target
69.77 USD
94% Upside
Highest
Price Target
105 USD
192% Upside
Immunocore Holdings PLC Competitors:
Price Targets
CPRX
Catalyst Pharmaceuticals Inc
45% Upside
397030
AprilBio Co Ltd
1% Upside
PRME
Prime Medicine Inc
78% Upside
086900
Medy Tox Inc
11% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
39% Upside
RARE
Ultragenyx Pharmaceutical Inc
141% Upside
ENTA
Enanta Pharmaceuticals Inc
20% Upside
CRSP
CRISPR Therapeutics AG
42% Upside

Revenue
Forecast

Revenue Estimate
Immunocore Holdings PLC

For the last 5 years the compound annual growth rate for Immunocore Holdings PLC's revenue is 65%. The projected CAGR for the next 4 years is 22%.

65%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Immunocore Holdings PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Immunocore Holdings PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMCR's stock price target?
Price Target
69.77 USD

According to Wall Street analysts, the average 1-year price target for IMCR is 69.77 USD with a low forecast of 36.36 USD and a high forecast of 105 USD.

What is Immunocore Holdings PLC's Revenue forecast?
Projected CAGR
22%

For the last 5 years the compound annual growth rate for Immunocore Holdings PLC's revenue is 65%. The projected CAGR for the next 4 years is 22%.

Back to Top